Clinical Research Directory
Browse clinical research sites, groups, and studies.
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
Sponsor: University Hospital, Brest
Summary
A lot of studies have demonstrated the prognostic value of post therapy 18F-FDG PET/CT in the management of uterine cervical cancer. Post therapy 18F-FDG PET/CT is usually requested by a lot of clinicians. Whereas 18F-FDG PET/CT is useful for prognosis in the follow-up, data are yet insufficient to clearly establish a formal recommendation. This prospective multicenter observational study will evaluate the interest of post therapy 18F-FDG PET/CT in clinical management (within 2 months of treatment) in patients with cervical cancer at an advanced stage. Main outcome : The therapeutic impact of post therapy 18F-FDG PET/CT (within 2 months after the end of therapy) will be evaluated on the complete results included MRI. Investigators will compare : * decision of clinicians without 18F-FDG PET/CT results * and decision of clinicians knowing entire results included results of 18F-FDG PET/CT.
Official title: Evaluation of the Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer at an Advanced Stage. Multicenter Prospective Observational Study
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2020-01-08
Completion Date
2026-02-05
Last Updated
2026-05-20
Healthy Volunteers
No
Conditions
Locations (2)
CHRU de Brest (Hôpital Morvan)
Brest, France
Centre Henri Becquerel
Rouen, France